Form 4: Gilead Sciences Executive Deborah H. Telman Reports Acquisition of Common Stock

EVP Deborah H. Telman reports acquisition of 12,371 shares of Gilead Sciences common stock following performance goal attainment.

Summary

• Deborah H. Telman, EVP, Corporate Affairs & GC of Gilead Sciences, reported a transaction on February 4, 2025.
• She acquired 12,371 shares of Gilead Sciences common stock.
• The acquisition was related to performance share awards granted on March 10, 2023, and March 10, 2024.
• The performance vesting requirement was satisfied upon certification by the Compensation and Talent Committee.
• Telman now beneficially owns 34,011 shares of Gilead Sciences common stock directly.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The vesting of performance shares suggests that the company has achieved certain performance goals, which is generally a positive sign. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• The satisfaction of performance goals indicates positive performance by the company, leading to the vesting of shares.

Future Outlook

The shares will be issued to the Reporting person when the requisite continuing service requirements are met.

Industry Context

Executive stock ownership changes are routinely monitored as indicators of management's confidence in the company's prospects. This filing reflects the vesting of performance-based compensation, which is a common practice in the pharmaceutical industry to align executive incentives with company performance.

Comparison to Industry Standards

• Performance-based equity compensation is a standard practice among large pharmaceutical companies like Pfizer, Merck, and Johnson & Johnson.
• These companies often use a mix of stock options, restricted stock units (RSUs), and performance shares to incentivize executives.
• The vesting of performance shares based on pre-defined goals is a common mechanism to ensure alignment with shareholder value creation.

Stakeholder Impact

• The vesting of performance shares aligns executive compensation with company performance, which is generally viewed positively by shareholders.
• The transaction itself has a minimal direct impact on other stakeholders.

Next Steps

• The shares will be issued to Deborah H. Telman upon meeting the continuing service requirements.

Key Dates